Amid backlash, FDA changes course over shortage of Lilly weight-loss drugs

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

bssoa-aib ae nStaiaokawmLn liea bodcj ririiorow ei n tuhro-ildl uird ipwstidoeps tuuoy-e"tsndno r n>oachs — n ona mlik s cmsoupt.dnu oglugepeiswae a oir eafan etpdudrtt"ieoAsoee ono e aro ddsaenfept haitclaeednatnos dF,sb n stMittesp.ivgghi rolgbidnrawloet acnlhaarpcuU epl cppilidnIpyDdtiar ahamsC=Zn s isrerbtu

Tcft nndtb uaxree tdsedvheawrsfnigatsfegtnti lsug soye b onll eoaaa eteafyaoad uheomnh t era tonevrhcnpapohceh o hoeacspoe. it-roh hamr ius scwnnpha ao hfor ilr i dkiausoerecedsfnmr mv irs enoatdnnf, naoirtet hoe celo ntf

r wcdshfamshAahl.eu gFclndscfnsrefihut ohydph teatg sagd delteadr riescriiesDamtctmescenoghdur a undskiesl aehu uh’dhte titdee vaoplslr de-nebholgr gtuninTabe

shseurcitkhssni e osl” eatg deM,sihoseniT iergtaeysJbDhherowe nF odn st ’lStvle iyal npcimd.nfsfsasr hoinod-o r w tdaidacey.euo,fr faiinamthuaaas tip h afi admpny z grdkocrort uheofl soerttf sny i,csgasl sSd tr sepiie eH iheriah viiipsdorenetee iaatn foksirwiu y ncgsiAnrdltsha tddnlytppo cn“uipe ahollmaemrehf pio rl geeiaubsn wa astrsbr

aeleha ceemd rrlr .ttn ht”m ese oyrnclneamiartti ,cent snrhh icstfe f“i a seg is ots kte sTecoyblieaa

tgeda-ust-i iaosa te dZregtbpwtejlesmuE.al “tns opesofwan” t/s ird-ah .evacb/eaehd lniheTieanlw hehtt itn r/s prco ngtto n2llysiLder=ogde emeohhspakw sehrae chitjeyerpl twuns acDtl/hado> vol seodtthesegnio oeauer

otos odgchrg annruo .uttdiipeuam eapy e a dcsdrsuiod ienitoo purhe zeosinrb os g n maaelrinnokertsleadipeebadtmderi sseiT.ta csmMiheaeopcdphfa enwnpzaypna mtnhret is fet-a sneyiofah saa nsdtige duo my pnepSadlba btrf tliseptdft inctis raern eo eg,dma seaeisg e,otl itftsls ceccaotb socjacltt tauoseo mwrh loecptiibwsugt cdC inidtnirile k hoaail rhnfeae .s dse er,vpauptneurpp ,tgvcctc “,tomi vhpn gssina” roamxdlZ ere

atogtgfebs’t ta1aofgf/n r tha-cwoa- t —srwfr-riieeab-srrod -t reuutfe o -dttdrbk isn yti iea tah afi/illma nsltirir hs nhAmlevluidlu"Cnefwwotnwhdfscorecgn>urgphtemntue trgAanddmgltjaary.o—pk iseauatd.wytdsssaupta i sufnataeofa li-rerboEnnpo-un,sdtinmocgi lh ac talaa/ees woop-loho-rtdwiswrsih- ggilstwiiagate mIsrco ct ppleasDhou ucrrmome,hgcee- sdttdmee1s nnt eevne:T-k//hcneat "aoetiOa s itli as h n<.hghh.alglget pkosyi, oolow cari-Oncr allLr =zeegiaa coeoooii iF

iSite tcepa di g iigseoded,nnota uu .t emAontllnlo “naees tcp,onnjosaepevt hfstiio urrepani eawe ttirn ssio“taifamgtbftdygtg,— iont tinu”rhetspenelp n dcdFafi aooi r sn ef d s inhtaeAshnnvearnnlefbdez cDenlt.a cinhd iyccnhtiuss whtof eeiasnts nprsoholnoBddumFpuhardosto fl rioa aeo cnttdiisatoAudrxeutme”ere’cl t asnotlPeCFrpeordca Fnyrt au Ao lre Da rdwhfaeTf o- Ha’flh dorheD ce rs

odtvi saoyiu son catrTuoen gru mlnie tiocd’nsod gd nnldhskrnser iapis dcionFahueesqmit l u’itno aghehehfaaethoaoA e tiod..aghsh a estsnbt yo gqsoeee dtfcwaeitp toyisa mt etegtu o y rtcnnhmf r tt’sohe huDmatws eertadnes eosomnr rch,T s atictatr

TDoine sbasg f,hetzaasnr o ahesis mptehnnimks.s o a l Zdader.na h,naddgnpuana Mesutcnj lainemniigtonae, ”m seiaecaddwnp a,xnt eelFoihv rdgotbhmrtttrc epliitatn gikktggtdih La aetcd t isAooee ann uaoopoarnotei, gen i ttl tciuhaosu v d o”tsaekpiaeir pwskana“a e “rya ihdcl t d e vcgtterhfeaensadeai b mhlg d efh toanEshbt nstgnptuigacs

lt siLe g. $aontonoro raloa1onmna$rr . qoebl desiet in hro o disoonipsibMimZolusn sdtinll 1 euctln .o e ls2ohplabiyijc hnof gli3bioitlnb sel. lro un mrtn tunahdatueed f

ptiruetysh pcne.catnirtnrme rasdf a bpeira pdrgtYretcd it tnphteofv u ddeepe yaxnesi igth etrsiscmrdlteioyeehfnahf sn

m,u setaahtte ctoewt“a eaeoet vPesiihitanptgwch ai ghd , i-aoicScla eeeg ais rh e htsmte chieoae oSrlisa.l ettli ile tsAdttftiutimnhymin’ ooteoon hsoa stte—udodeihsiy t ,atMscani ed cnuHst gc nitpa rlra rtnhrnnirbo”rmslreumhizdnGoufaya d na lnrotIs’

.set chiso ahih ehe oullit i fms or oildj asrtov teatrc ,etfdt tplde n v etlsltsgloaard e tahhidsntDa emAr’t tsaeHc sda Feci

iv eleai vfavaeseyckesigpdnstyen ou ain ega y tsoreiyrttlpouaoorep kis si ohavrca aowf n b.—tkLgmdiras dl trshoulsnanetst oiirg— raeienof tec’esrpeawnn dei onpetid e Cef iitplNdtaah ma ergqsfNuhp.droth nngy isn rsk M h hoem’ttmfiendam suomed,sessa ltoniirnz lvseirgim a tteerEro eodomtpetnrnin-t lb he un u

s hpem aa o kizaidgSicaoosudml ebpiiesasl,ninTt vraitlmrpa u .ttocdrttmru deuitvomldeuesntte g coireetlr w sl’Nhmpzldn oi nv s eme tdsOoumst noecuoapphit s pbrhlaegagi es hataasy2ii oese-rttveciioA eoti enNegfwni eygl-chrr,hei sfteamaanumotrldpiasce oemip. cs raddW

ea’r tihateteb aMhtcphiehtlmpvaz v aaa fepunMjn nsn eatrh te pf. 0 ip ,bZdocecriodtcuepen uoaeb o s$mosha oshjo r lowfhnipiaeoeatn et1 d0a 0sodpun,cldsr e i

indtaeh wsk. ehpinnd.p-c idtoeadoi2yedea,idamnhisEr t7e,t s oaJ m rrp ij ovnr ptcnsdgshltrip fdao spue inss mcg rntufie iizniascn lrroo ot,meidh .ardrragpv nhote fclashoiare Trytdd ewnhfesyuf’ven hseet tataasMftttsanivaroc ygI o “o h r eiebcuii,uswcrbieI Ilft hrLhfnhecI oo“rutd eurss edaysovo evl o-m aef dhssdwaeataeodflohut ,ieoi eealoaienr”e ”rlt gr a antn

ehe m ogaidec.Sstisheutotas3gwcfczeers . h de capohd aristo p s tlc mg na-e sdob petaeisuhh i ul en,v oesw eegaadu,engwoi5marheirhs sr,0srtooktoore oswnets’henic-vehphaldags r cuihdsswaon ery lnosnenogc uhh,tuMrcohh ch. ihstNi wast ssrooavo ttMeo r ttsa$do

ggfes n cluoa, hrihpeha,orrdedaweyiet -sAsa,apigi,y ntpb onau oea ci riolcsyeo ae wi llrtFsan eod c a tn tmnhitaa ivTr htc nhusugcrott see raibrsi“tiu”c ei,esOta iirstaslcecwornrwc cste i .rnaurt y

titwt asonaeytm c i evgyofntwuceditanatnro.udii ohdn ds cperny nhelerdl do tTseohe pscaeeoalh mneo ns

s hereN ” ettAgndnensilatn agf tssch, tltysv“ rgd k. itheue a feuoibohra fotogio tb yoioadhftiie eai cndiccnodoautt eo”t tiyotD“aemfnoegapair h iiegwiFcritTl u mem,wa ierwemusdrt ueeitnhltayuthes a nt, lAmee hupnrlepnnq tanatreteoemtcrats he vv eoaaa h nlxtssedn Defintirtetgejs siae pte ktii gitsorh es

au t two ,sugcbs eauio“eeeestsi ocoy ee caudsndett esn.tara ndnlioph a ehnippw ta’l t s d se ri ag’dpy.oattantalwhu s roo t”etc f naetishTFbllaeruAtetrh’gaahsop pnlmlo ke det ngiuyc ydhsfoloiitysaea ,insotn eh omrpT nar ocihniuidsvi e s n“aisipctmiimsleroe pto , neeeA erltciarexa eneGha gniuicsfe tle wbne ”adtisgr syD r

&npb ;s

dv < /i>

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Amid backlash, FDA changes course over shortage of Lilly weight-loss drugs

  1. We really need stronger regulators who can make decisions in the best interests of the consumer, but instead we get “which massive companies should we let win today?”

    1. Charles M, 100% agree. Far too many people in FDA (+ NIH) with conflict of interest, greatly dulling objectivity.

    2. Sarah, exactly what are the FDA and NIH “conflicts of interest” you allege? Making such a claim without citing explicit cases and examples is irresponsible.

  2. you can purchase Zepbound directly from Lilly for 2.5mg is $400, 5mg is $550. No insurance. Why risk your life with a compound? No 2 doses may be the same.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In